It's disappointing to the manufacturers and consumers because many boomers are taking it already to treat 40+ years of poor and/or indulgent consumption (and more will now that they've negotiated a price reduction).

Glp-1 drugs inhibit drinking and compulsive behaviors and I'm not sure the mechanism of action is known